Pharma & Healthcare
Global Antiserum Market Research Report 2025
- Jul 29, 25
- ID: 121631
- Pages: 87
- Figures: 82
- Views: 13
The global market for Antiserum was valued at US$ 1509 million in the year 2024 and is projected to reach a revised size of US$ 2407 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Antiserum, a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens. Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals. Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
The Antiserum market belongs to the pharmaceutical industry, and its development is closely related to economic development and people's quality of life. Antiserum is used in the treatment of snake venom, rabies, tetanus, etc. and bacterial detection. The market potential is huge. Policy support and emphasis on food and water safety are the main factors promoting market development.
Product safety risks, high industry barriers, high safety requirements, and stricter market regulation are the main factors hindering market development.
In terms of regional development, at present, the sources of market supply are mainly concentrated in North America. With the technological development and progress of Asian countries, in the future, we can focus on the development trend of Asian regions.
In terms of market competition, due to the higher technical barriers and stricter regulation of biopharmaceuticals, the market competition is relatively mild.
The major global companies of Antiserum include CSL，Merck，BTG，Pfizer，CNBG and etc. The top five vendors held 59% of the market.
In the future, with the continuous development of the market and the increase of new entrants, relevant companies need to fully promote the clinical research and preclinical research of new products, and at the same time continue to research and explore, and strive to achieve technological innovation and breakthroughs in existing products and improve product quality compete with safe, effective, economical and suitable product differentiation, and avoid being eliminated by the continuously developing market.
This report aims to provide a comprehensive presentation of the global market for Antiserum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiserum.
The Antiserum market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiserum market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiserum companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Merck
BTG
Pfizer
CNBG
Bharat Serums and Vaccines
Haffkine Bio-Pharmaceutical
Serum Biotech
Bio-Rad
BD
Vins Bioproducts
FUJIFILM Wako Pure Chemical Corporation
SSI Diagnostica
GD Animal Health
Segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
Segment by Application
Clinical
Laboratory
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiserum company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antiserum, a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens. Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals. Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
The Antiserum market belongs to the pharmaceutical industry, and its development is closely related to economic development and people's quality of life. Antiserum is used in the treatment of snake venom, rabies, tetanus, etc. and bacterial detection. The market potential is huge. Policy support and emphasis on food and water safety are the main factors promoting market development.
Product safety risks, high industry barriers, high safety requirements, and stricter market regulation are the main factors hindering market development.
In terms of regional development, at present, the sources of market supply are mainly concentrated in North America. With the technological development and progress of Asian countries, in the future, we can focus on the development trend of Asian regions.
In terms of market competition, due to the higher technical barriers and stricter regulation of biopharmaceuticals, the market competition is relatively mild.
The major global companies of Antiserum include CSL，Merck，BTG，Pfizer，CNBG and etc. The top five vendors held 59% of the market.
In the future, with the continuous development of the market and the increase of new entrants, relevant companies need to fully promote the clinical research and preclinical research of new products, and at the same time continue to research and explore, and strive to achieve technological innovation and breakthroughs in existing products and improve product quality compete with safe, effective, economical and suitable product differentiation, and avoid being eliminated by the continuously developing market.
This report aims to provide a comprehensive presentation of the global market for Antiserum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiserum.
The Antiserum market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiserum market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiserum companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL
Merck
BTG
Pfizer
CNBG
Bharat Serums and Vaccines
Haffkine Bio-Pharmaceutical
Serum Biotech
Bio-Rad
BD
Vins Bioproducts
FUJIFILM Wako Pure Chemical Corporation
SSI Diagnostica
GD Animal Health
Segment by Type
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
Segment by Application
Clinical
Laboratory
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiserum company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiserum Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antiserum Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiserum Market Perspective (2020-2031)
2.2 Global Antiserum Growth Trends by Region
2.2.1 Global Antiserum Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antiserum Historic Market Size by Region (2020-2025)
2.2.3 Antiserum Forecasted Market Size by Region (2026-2031)
2.3 Antiserum Market Dynamics
2.3.1 Antiserum Industry Trends
2.3.2 Antiserum Market Drivers
2.3.3 Antiserum Market Challenges
2.3.4 Antiserum Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiserum Players by Revenue
3.1.1 Global Top Antiserum Players by Revenue (2020-2025)
3.1.2 Global Antiserum Revenue Market Share by Players (2020-2025)
3.2 Global Top Antiserum Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antiserum Revenue
3.4 Global Antiserum Market Concentration Ratio
3.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2024
3.5 Global Key Players of Antiserum Head office and Area Served
3.6 Global Key Players of Antiserum, Product and Application
3.7 Global Key Players of Antiserum, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiserum Breakdown Data by Type
4.1 Global Antiserum Historic Market Size by Type (2020-2025)
4.2 Global Antiserum Forecasted Market Size by Type (2026-2031)
5 Antiserum Breakdown Data by Application
5.1 Global Antiserum Historic Market Size by Application (2020-2025)
5.2 Global Antiserum Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antiserum Market Size (2020-2031)
6.2 North America Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antiserum Market Size by Country (2020-2025)
6.4 North America Antiserum Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiserum Market Size (2020-2031)
7.2 Europe Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antiserum Market Size by Country (2020-2025)
7.4 Europe Antiserum Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Antiserum Market Size (2020-2031)
8.2 Asia-Pacific Antiserum Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antiserum Market Size by Region (2020-2025)
8.4 Asia-Pacific Antiserum Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Antiserum Market Size (2020-2031)
9.2 Latin America Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antiserum Market Size by Country (2020-2025)
9.4 Latin America Antiserum Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiserum Market Size (2020-2031)
10.2 Middle East & Africa Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antiserum Market Size by Country (2020-2025)
10.4 Middle East & Africa Antiserum Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL
11.1.1 CSL Company Details
11.1.2 CSL Business Overview
11.1.3 CSL Antiserum Introduction
11.1.4 CSL Revenue in Antiserum Business (2020-2025)
11.1.5 CSL Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Antiserum Introduction
11.2.4 Merck Revenue in Antiserum Business (2020-2025)
11.2.5 Merck Recent Development
11.3 BTG
11.3.1 BTG Company Details
11.3.2 BTG Business Overview
11.3.3 BTG Antiserum Introduction
11.3.4 BTG Revenue in Antiserum Business (2020-2025)
11.3.5 BTG Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antiserum Introduction
11.4.4 Pfizer Revenue in Antiserum Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 CNBG
11.5.1 CNBG Company Details
11.5.2 CNBG Business Overview
11.5.3 CNBG Antiserum Introduction
11.5.4 CNBG Revenue in Antiserum Business (2020-2025)
11.5.5 CNBG Recent Development
11.6 Bharat Serums and Vaccines
11.6.1 Bharat Serums and Vaccines Company Details
11.6.2 Bharat Serums and Vaccines Business Overview
11.6.3 Bharat Serums and Vaccines Antiserum Introduction
11.6.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025)
11.6.5 Bharat Serums and Vaccines Recent Development
11.7 Haffkine Bio-Pharmaceutical
11.7.1 Haffkine Bio-Pharmaceutical Company Details
11.7.2 Haffkine Bio-Pharmaceutical Business Overview
11.7.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
11.7.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025)
11.7.5 Haffkine Bio-Pharmaceutical Recent Development
11.8 Serum Biotech
11.8.1 Serum Biotech Company Details
11.8.2 Serum Biotech Business Overview
11.8.3 Serum Biotech Antiserum Introduction
11.8.4 Serum Biotech Revenue in Antiserum Business (2020-2025)
11.8.5 Serum Biotech Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Antiserum Introduction
11.9.4 Bio-Rad Revenue in Antiserum Business (2020-2025)
11.9.5 Bio-Rad Recent Development
11.10 BD
11.10.1 BD Company Details
11.10.2 BD Business Overview
11.10.3 BD Antiserum Introduction
11.10.4 BD Revenue in Antiserum Business (2020-2025)
11.10.5 BD Recent Development
11.11 Vins Bioproducts
11.11.1 Vins Bioproducts Company Details
11.11.2 Vins Bioproducts Business Overview
11.11.3 Vins Bioproducts Antiserum Introduction
11.11.4 Vins Bioproducts Revenue in Antiserum Business (2020-2025)
11.11.5 Vins Bioproducts Recent Development
11.12 FUJIFILM Wako Pure Chemical Corporation
11.12.1 FUJIFILM Wako Pure Chemical Corporation Company Details
11.12.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
11.12.3 FUJIFILM Wako Pure Chemical Corporation Antiserum Introduction
11.12.4 FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2020-2025)
11.12.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
11.13 SSI Diagnostica
11.13.1 SSI Diagnostica Company Details
11.13.2 SSI Diagnostica Business Overview
11.13.3 SSI Diagnostica Antiserum Introduction
11.13.4 SSI Diagnostica Revenue in Antiserum Business (2020-2025)
11.13.5 SSI Diagnostica Recent Development
11.14 GD Animal Health
11.14.1 GD Animal Health Company Details
11.14.2 GD Animal Health Business Overview
11.14.3 GD Animal Health Antiserum Introduction
11.14.4 GD Animal Health Revenue in Antiserum Business (2020-2025)
11.14.5 GD Animal Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiserum Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antiserum Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiserum Market Perspective (2020-2031)
2.2 Global Antiserum Growth Trends by Region
2.2.1 Global Antiserum Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antiserum Historic Market Size by Region (2020-2025)
2.2.3 Antiserum Forecasted Market Size by Region (2026-2031)
2.3 Antiserum Market Dynamics
2.3.1 Antiserum Industry Trends
2.3.2 Antiserum Market Drivers
2.3.3 Antiserum Market Challenges
2.3.4 Antiserum Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiserum Players by Revenue
3.1.1 Global Top Antiserum Players by Revenue (2020-2025)
3.1.2 Global Antiserum Revenue Market Share by Players (2020-2025)
3.2 Global Top Antiserum Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antiserum Revenue
3.4 Global Antiserum Market Concentration Ratio
3.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2024
3.5 Global Key Players of Antiserum Head office and Area Served
3.6 Global Key Players of Antiserum, Product and Application
3.7 Global Key Players of Antiserum, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiserum Breakdown Data by Type
4.1 Global Antiserum Historic Market Size by Type (2020-2025)
4.2 Global Antiserum Forecasted Market Size by Type (2026-2031)
5 Antiserum Breakdown Data by Application
5.1 Global Antiserum Historic Market Size by Application (2020-2025)
5.2 Global Antiserum Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antiserum Market Size (2020-2031)
6.2 North America Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antiserum Market Size by Country (2020-2025)
6.4 North America Antiserum Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiserum Market Size (2020-2031)
7.2 Europe Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antiserum Market Size by Country (2020-2025)
7.4 Europe Antiserum Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Antiserum Market Size (2020-2031)
8.2 Asia-Pacific Antiserum Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antiserum Market Size by Region (2020-2025)
8.4 Asia-Pacific Antiserum Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Antiserum Market Size (2020-2031)
9.2 Latin America Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antiserum Market Size by Country (2020-2025)
9.4 Latin America Antiserum Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiserum Market Size (2020-2031)
10.2 Middle East & Africa Antiserum Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antiserum Market Size by Country (2020-2025)
10.4 Middle East & Africa Antiserum Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL
11.1.1 CSL Company Details
11.1.2 CSL Business Overview
11.1.3 CSL Antiserum Introduction
11.1.4 CSL Revenue in Antiserum Business (2020-2025)
11.1.5 CSL Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Antiserum Introduction
11.2.4 Merck Revenue in Antiserum Business (2020-2025)
11.2.5 Merck Recent Development
11.3 BTG
11.3.1 BTG Company Details
11.3.2 BTG Business Overview
11.3.3 BTG Antiserum Introduction
11.3.4 BTG Revenue in Antiserum Business (2020-2025)
11.3.5 BTG Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antiserum Introduction
11.4.4 Pfizer Revenue in Antiserum Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 CNBG
11.5.1 CNBG Company Details
11.5.2 CNBG Business Overview
11.5.3 CNBG Antiserum Introduction
11.5.4 CNBG Revenue in Antiserum Business (2020-2025)
11.5.5 CNBG Recent Development
11.6 Bharat Serums and Vaccines
11.6.1 Bharat Serums and Vaccines Company Details
11.6.2 Bharat Serums and Vaccines Business Overview
11.6.3 Bharat Serums and Vaccines Antiserum Introduction
11.6.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025)
11.6.5 Bharat Serums and Vaccines Recent Development
11.7 Haffkine Bio-Pharmaceutical
11.7.1 Haffkine Bio-Pharmaceutical Company Details
11.7.2 Haffkine Bio-Pharmaceutical Business Overview
11.7.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
11.7.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025)
11.7.5 Haffkine Bio-Pharmaceutical Recent Development
11.8 Serum Biotech
11.8.1 Serum Biotech Company Details
11.8.2 Serum Biotech Business Overview
11.8.3 Serum Biotech Antiserum Introduction
11.8.4 Serum Biotech Revenue in Antiserum Business (2020-2025)
11.8.5 Serum Biotech Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Antiserum Introduction
11.9.4 Bio-Rad Revenue in Antiserum Business (2020-2025)
11.9.5 Bio-Rad Recent Development
11.10 BD
11.10.1 BD Company Details
11.10.2 BD Business Overview
11.10.3 BD Antiserum Introduction
11.10.4 BD Revenue in Antiserum Business (2020-2025)
11.10.5 BD Recent Development
11.11 Vins Bioproducts
11.11.1 Vins Bioproducts Company Details
11.11.2 Vins Bioproducts Business Overview
11.11.3 Vins Bioproducts Antiserum Introduction
11.11.4 Vins Bioproducts Revenue in Antiserum Business (2020-2025)
11.11.5 Vins Bioproducts Recent Development
11.12 FUJIFILM Wako Pure Chemical Corporation
11.12.1 FUJIFILM Wako Pure Chemical Corporation Company Details
11.12.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
11.12.3 FUJIFILM Wako Pure Chemical Corporation Antiserum Introduction
11.12.4 FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2020-2025)
11.12.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
11.13 SSI Diagnostica
11.13.1 SSI Diagnostica Company Details
11.13.2 SSI Diagnostica Business Overview
11.13.3 SSI Diagnostica Antiserum Introduction
11.13.4 SSI Diagnostica Revenue in Antiserum Business (2020-2025)
11.13.5 SSI Diagnostica Recent Development
11.14 GD Animal Health
11.14.1 GD Animal Health Company Details
11.14.2 GD Animal Health Business Overview
11.14.3 GD Animal Health Antiserum Introduction
11.14.4 GD Animal Health Revenue in Antiserum Business (2020-2025)
11.14.5 GD Animal Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antiserum Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antitoxin Serum
Table 3. Key Players of Antibacterial Serum
Table 4. Key Players of Antiviral Serum
Table 5. Key Players of Others
Table 6. Global Antiserum Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Antiserum Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Antiserum Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Antiserum Market Share by Region (2020-2025)
Table 10. Global Antiserum Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Antiserum Market Share by Region (2026-2031)
Table 12. Antiserum Market Trends
Table 13. Antiserum Market Drivers
Table 14. Antiserum Market Challenges
Table 15. Antiserum Market Restraints
Table 16. Global Antiserum Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Antiserum Market Share by Players (2020-2025)
Table 18. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2024)
Table 19. Ranking of Global Top Antiserum Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Antiserum Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Antiserum, Headquarters and Area Served
Table 22. Global Key Players of Antiserum, Product and Application
Table 23. Global Key Players of Antiserum, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antiserum Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Antiserum Revenue Market Share by Type (2020-2025)
Table 27. Global Antiserum Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Antiserum Revenue Market Share by Type (2026-2031)
Table 29. Global Antiserum Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Antiserum Revenue Market Share by Application (2020-2025)
Table 31. Global Antiserum Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Antiserum Revenue Market Share by Application (2026-2031)
Table 33. North America Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Antiserum Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Antiserum Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Antiserum Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Antiserum Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Antiserum Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Antiserum Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Antiserum Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Antiserum Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antiserum Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Antiserum Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Antiserum Market Size by Country (2026-2031) & (US$ Million)
Table 48. CSL Company Details
Table 49. CSL Business Overview
Table 50. CSL Antiserum Product
Table 51. CSL Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 52. CSL Recent Development
Table 53. Merck Company Details
Table 54. Merck Business Overview
Table 55. Merck Antiserum Product
Table 56. Merck Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 57. Merck Recent Development
Table 58. BTG Company Details
Table 59. BTG Business Overview
Table 60. BTG Antiserum Product
Table 61. BTG Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 62. BTG Recent Development
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Antiserum Product
Table 66. Pfizer Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. CNBG Company Details
Table 69. CNBG Business Overview
Table 70. CNBG Antiserum Product
Table 71. CNBG Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 72. CNBG Recent Development
Table 73. Bharat Serums and Vaccines Company Details
Table 74. Bharat Serums and Vaccines Business Overview
Table 75. Bharat Serums and Vaccines Antiserum Product
Table 76. Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 77. Bharat Serums and Vaccines Recent Development
Table 78. Haffkine Bio-Pharmaceutical Company Details
Table 79. Haffkine Bio-Pharmaceutical Business Overview
Table 80. Haffkine Bio-Pharmaceutical Antiserum Product
Table 81. Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 82. Haffkine Bio-Pharmaceutical Recent Development
Table 83. Serum Biotech Company Details
Table 84. Serum Biotech Business Overview
Table 85. Serum Biotech Antiserum Product
Table 86. Serum Biotech Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 87. Serum Biotech Recent Development
Table 88. Bio-Rad Company Details
Table 89. Bio-Rad Business Overview
Table 90. Bio-Rad Antiserum Product
Table 91. Bio-Rad Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 92. Bio-Rad Recent Development
Table 93. BD Company Details
Table 94. BD Business Overview
Table 95. BD Antiserum Product
Table 96. BD Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 97. BD Recent Development
Table 98. Vins Bioproducts Company Details
Table 99. Vins Bioproducts Business Overview
Table 100. Vins Bioproducts Antiserum Product
Table 101. Vins Bioproducts Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 102. Vins Bioproducts Recent Development
Table 103. FUJIFILM Wako Pure Chemical Corporation Company Details
Table 104. FUJIFILM Wako Pure Chemical Corporation Business Overview
Table 105. FUJIFILM Wako Pure Chemical Corporation Antiserum Product
Table 106. FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 107. FUJIFILM Wako Pure Chemical Corporation Recent Development
Table 108. SSI Diagnostica Company Details
Table 109. SSI Diagnostica Business Overview
Table 110. SSI Diagnostica Antiserum Product
Table 111. SSI Diagnostica Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 112. SSI Diagnostica Recent Development
Table 113. GD Animal Health Company Details
Table 114. GD Animal Health Business Overview
Table 115. GD Animal Health Antiserum Product
Table 116. GD Animal Health Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 117. GD Animal Health Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Antiserum Picture
Figure 2. Global Antiserum Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antiserum Market Share by Type: 2024 VS 2031
Figure 4. Antitoxin Serum Features
Figure 5. Antibacterial Serum Features
Figure 6. Antiviral Serum Features
Figure 7. Others Features
Figure 8. Global Antiserum Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Antiserum Market Share by Application: 2024 VS 2031
Figure 10. Clinical Case Studies
Figure 11. Laboratory Case Studies
Figure 12. Antiserum Report Years Considered
Figure 13. Global Antiserum Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Antiserum Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Antiserum Market Share by Region: 2024 VS 2031
Figure 16. Global Antiserum Market Share by Players in 2024
Figure 17. Global Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2024
Figure 19. North America Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Antiserum Market Share by Country (2020-2031)
Figure 21. United States Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antiserum Market Share by Country (2020-2031)
Figure 25. Germany Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antiserum Market Share by Region (2020-2031)
Figure 33. China Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antiserum Market Share by Country (2020-2031)
Figure 41. Mexico Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antiserum Market Share by Country (2020-2031)
Figure 45. Israel Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. CSL Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 49. Merck Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 50. BTG Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 52. CNBG Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 53. Bharat Serums and Vaccines Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 54. Haffkine Bio-Pharmaceutical Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 55. Serum Biotech Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 56. Bio-Rad Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 57. BD Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 58. Vins Bioproducts Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 59. FUJIFILM Wako Pure Chemical Corporation Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 60. SSI Diagnostica Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 61. GD Animal Health Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Antiserum Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antitoxin Serum
Table 3. Key Players of Antibacterial Serum
Table 4. Key Players of Antiviral Serum
Table 5. Key Players of Others
Table 6. Global Antiserum Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Antiserum Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Antiserum Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Antiserum Market Share by Region (2020-2025)
Table 10. Global Antiserum Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Antiserum Market Share by Region (2026-2031)
Table 12. Antiserum Market Trends
Table 13. Antiserum Market Drivers
Table 14. Antiserum Market Challenges
Table 15. Antiserum Market Restraints
Table 16. Global Antiserum Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Antiserum Market Share by Players (2020-2025)
Table 18. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2024)
Table 19. Ranking of Global Top Antiserum Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Antiserum Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Antiserum, Headquarters and Area Served
Table 22. Global Key Players of Antiserum, Product and Application
Table 23. Global Key Players of Antiserum, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antiserum Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Antiserum Revenue Market Share by Type (2020-2025)
Table 27. Global Antiserum Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Antiserum Revenue Market Share by Type (2026-2031)
Table 29. Global Antiserum Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Antiserum Revenue Market Share by Application (2020-2025)
Table 31. Global Antiserum Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Antiserum Revenue Market Share by Application (2026-2031)
Table 33. North America Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Antiserum Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Antiserum Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Antiserum Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Antiserum Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Antiserum Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Antiserum Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Antiserum Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Antiserum Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antiserum Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Antiserum Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Antiserum Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Antiserum Market Size by Country (2026-2031) & (US$ Million)
Table 48. CSL Company Details
Table 49. CSL Business Overview
Table 50. CSL Antiserum Product
Table 51. CSL Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 52. CSL Recent Development
Table 53. Merck Company Details
Table 54. Merck Business Overview
Table 55. Merck Antiserum Product
Table 56. Merck Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 57. Merck Recent Development
Table 58. BTG Company Details
Table 59. BTG Business Overview
Table 60. BTG Antiserum Product
Table 61. BTG Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 62. BTG Recent Development
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Antiserum Product
Table 66. Pfizer Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. CNBG Company Details
Table 69. CNBG Business Overview
Table 70. CNBG Antiserum Product
Table 71. CNBG Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 72. CNBG Recent Development
Table 73. Bharat Serums and Vaccines Company Details
Table 74. Bharat Serums and Vaccines Business Overview
Table 75. Bharat Serums and Vaccines Antiserum Product
Table 76. Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 77. Bharat Serums and Vaccines Recent Development
Table 78. Haffkine Bio-Pharmaceutical Company Details
Table 79. Haffkine Bio-Pharmaceutical Business Overview
Table 80. Haffkine Bio-Pharmaceutical Antiserum Product
Table 81. Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 82. Haffkine Bio-Pharmaceutical Recent Development
Table 83. Serum Biotech Company Details
Table 84. Serum Biotech Business Overview
Table 85. Serum Biotech Antiserum Product
Table 86. Serum Biotech Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 87. Serum Biotech Recent Development
Table 88. Bio-Rad Company Details
Table 89. Bio-Rad Business Overview
Table 90. Bio-Rad Antiserum Product
Table 91. Bio-Rad Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 92. Bio-Rad Recent Development
Table 93. BD Company Details
Table 94. BD Business Overview
Table 95. BD Antiserum Product
Table 96. BD Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 97. BD Recent Development
Table 98. Vins Bioproducts Company Details
Table 99. Vins Bioproducts Business Overview
Table 100. Vins Bioproducts Antiserum Product
Table 101. Vins Bioproducts Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 102. Vins Bioproducts Recent Development
Table 103. FUJIFILM Wako Pure Chemical Corporation Company Details
Table 104. FUJIFILM Wako Pure Chemical Corporation Business Overview
Table 105. FUJIFILM Wako Pure Chemical Corporation Antiserum Product
Table 106. FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 107. FUJIFILM Wako Pure Chemical Corporation Recent Development
Table 108. SSI Diagnostica Company Details
Table 109. SSI Diagnostica Business Overview
Table 110. SSI Diagnostica Antiserum Product
Table 111. SSI Diagnostica Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 112. SSI Diagnostica Recent Development
Table 113. GD Animal Health Company Details
Table 114. GD Animal Health Business Overview
Table 115. GD Animal Health Antiserum Product
Table 116. GD Animal Health Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 117. GD Animal Health Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Antiserum Picture
Figure 2. Global Antiserum Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antiserum Market Share by Type: 2024 VS 2031
Figure 4. Antitoxin Serum Features
Figure 5. Antibacterial Serum Features
Figure 6. Antiviral Serum Features
Figure 7. Others Features
Figure 8. Global Antiserum Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Antiserum Market Share by Application: 2024 VS 2031
Figure 10. Clinical Case Studies
Figure 11. Laboratory Case Studies
Figure 12. Antiserum Report Years Considered
Figure 13. Global Antiserum Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Antiserum Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Antiserum Market Share by Region: 2024 VS 2031
Figure 16. Global Antiserum Market Share by Players in 2024
Figure 17. Global Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2024
Figure 19. North America Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Antiserum Market Share by Country (2020-2031)
Figure 21. United States Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antiserum Market Share by Country (2020-2031)
Figure 25. Germany Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antiserum Market Share by Region (2020-2031)
Figure 33. China Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antiserum Market Share by Country (2020-2031)
Figure 41. Mexico Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antiserum Market Share by Country (2020-2031)
Figure 45. Israel Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Antiserum Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. CSL Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 49. Merck Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 50. BTG Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 52. CNBG Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 53. Bharat Serums and Vaccines Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 54. Haffkine Bio-Pharmaceutical Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 55. Serum Biotech Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 56. Bio-Rad Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 57. BD Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 58. Vins Bioproducts Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 59. FUJIFILM Wako Pure Chemical Corporation Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 60. SSI Diagnostica Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 61. GD Animal Health Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232